Biocon Limited (BIOCON)
NSE
Biocon Limited (BIOCON) was last quoted at ₹360.00, -2.47% for the session. See its NSE share price, chart and company data on TechGraph.
Current Biocon Limited forecasts and price targets
Analyst figures are shown only when the research feed provides them.
Scroll here to load data.
People also watch
Trending global stocks
About Biocon Limited
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries,…
Founded byKiran Mazumdar-Shaw
Technical analysis
| Indicator | Call | Detail |
|---|---|---|
| Price vs SMA 20 | Sell | Last close is below the 20-session average. |
| Price vs SMA 50 | Sell | Medium-term trend is down. |
| SMA cross | Sell | The 20-session average is below the 50-session average. |
| RSI (14) | Neutral | RSI is in the mid-range. |
| MACD | Sell | MACD line is below zero. |
| Stochastic | Buy | Stochastic %K is oversold. |
Company profile
Biocon Limited executives and management
Biocon Limited financials and ownership
Biocon Limited revenue, operating income and earnings per share
Annual figures are charted only when the provider supplies comparable periods.
Scroll here to load data.
Key financial metrics
Financial Highlights
| Profit Margin | +2.86% |
| Operating Margin | +8.59% |
| Return on Assets | N/A |
| Return on Equity | N/A |
| Revenue | N/A |
| Quarterly Revenue Growth | N/A |
| Diluted EPS | N/A |
Balance Sheet
| Total Cash | N/A |
| Total Debt | N/A |
| Total Debt/Equity | N/A |
| Current Ratio | N/A |
| Book Value Per Share | N/A |
Cash Flow Statement
| Operating Cash Flow | N/A |
| Levered Free Cash Flow | N/A |
Share Statistics
| Avg Vol (3 month) | N/A |
| Shares Outstanding | 1.63B |
| Float | N/A |
| Short Ratio | N/A |
| Short % of Float | N/A |
Major Holders
| % of Shares Held by All Insiders | N/A |
| % of Shares Held by Institutions | N/A |
| % of Float Held by Institutions | N/A |
| Number of Institutions Holding Shares | N/A |
Financial statement fields will appear when the market-data feed provides usable fundamentals for this instrument.
Biocon Limited revenue by segment
Scroll here to load data.
Biocon Limited stock margins
Scroll here to load data.
Biocon Limited historical valuation
Scroll here to load data.
Biocon Limited annual returns
Scroll here to load data.
Biocon Limited financial statements
Income statement, balance sheet and cash flow, with annual and quarterly periods.
Scroll here to load statements.
News & official updates
TechGraph News · 2023-11-30Biocon Biologics Successfully Completes Integration of Viatris’ Biosimilar Business in 31 Countries in Europe
TechGraph News · 2020-02-27Biocon receives two observations from USFDA for API Manufacturing Facility in Bengaluru
TechGraph News · 2019-03-02Biocon appoints Christiane Hamacher as the CEO of Biocon Biologics Ltd
Biocon Limited fair value
Scroll here to load data.
Verify with NSE shareholding filings →
Biocon Limited options chain
Scroll here to load data.
Biocon Limited — frequently asked questions
What is the share price of Biocon Limited (BIOCON) today?
Biocon Limited (BIOCON) last traded at ₹360.00 (-2.47%) on NSE, according to TechGraph market data.
Where is Biocon Limited listed?
Biocon Limited trades as BIOCON on NSE.
What is the 52-week range for BIOCON?
The 52-week range for BIOCON is ₹337.70 to ₹447.15.
Price quotes refresh periodically while this page stays open; the chart follows the quote and refreshes exchange history less often. Some venues delay data by 0–15 minutes. When the market is closed, the last recorded session price is shown. Fundamentals refresh on a slower schedule.